News for 'Organisation of Pharmaceutical Producers in India'

Pharma industry wants Budget to offer tax clarity

Pharma industry wants Budget to offer tax clarity

Rediff.com24 Jan 2017

Pharma body wants all excisable goods used for R&D purposes should be exempted from central excise duty.

US to deploy more supplies, support to Covid-hit India: Blinken

US to deploy more supplies, support to Covid-hit India: Blinken

Rediff.com25 Apr 2021

US Secretary of State Antony Blinken on Saturday (local time) said the US is working closely with its partners in the Indian government to deploy more supplies and additional support amid the record upsurge in Covid-19 infections in the country.

'Government of India should own responsibility of universal vaccination'

'Government of India should own responsibility of universal vaccination'

Rediff.com29 May 2021

'The vaccine policy should be such that all people should get the vaccine free.'

'PVR-INOX Merger In Final Stages'

'PVR-INOX Merger In Final Stages'

Rediff.com14 Jan 2023

'We would love to have more players entering the market because that is how the business will grow.'

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

India eyes oil-for-drugs deal with Venezuela to recoup pharma cash

Rediff.com18 May 2016

Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency

India's COVID vaccine rollout has rescued the world: Top US scientist

India's COVID vaccine rollout has rescued the world: Top US scientist

Rediff.com7 Mar 2021

During the webinar, 'COVID-19: Vaccination and Potential Return to Normalcy - If and When', Dr Hotez, an internationally-recognised physician-scientist in neglected tropical diseases and vaccine development, said that the COVID-19 vaccine rollout is "India's gift' to the world in combating the virus.

Bharat Biotech to rectify issues with Covaxin raised by WHO

Bharat Biotech to rectify issues with Covaxin raised by WHO

Rediff.com5 Apr 2022

According to sources close to ANI, "Bharat Biotech has informed Union health ministry that it will rectify the issues pointed out by WHO in 15 to 20 days." "World Health Organisation (WHO)'s suspension is not related to safety or efficacy issues but limited only to supply for United Nations agencies."

'Famotidine may become the next HCQ for Covid-19'

'Famotidine may become the next HCQ for Covid-19'

Rediff.com10 May 2020

Researchers at Northwell Health in New York are testing the effects on Famotidine (used in high intravenous doses) on Covid-19 patients as a potential treatment. After the hospital announced its clinical trials, it led to a drug shortage in the US. Back home, however, there has not been any surge in the demand for Famotidine yet.

Mutual vaccine recognition eases international travel: Modi

Mutual vaccine recognition eases international travel: Modi

Rediff.com23 Sep 2021

Prime Minister Narendra Modi said on Wednesday that international travel should be made easier through mutual recognition of vaccine certificates, amid several countries adopting different sets of rules to allow foreigners to enter their territory in the wake of the COVID-19 pandemic.

Drug retailers set to compete with pharma majors

Drug retailers set to compete with pharma majors

Rediff.com19 Jul 2010

Over 550,000 small drug retailers in the country are transforming into producers and marketers of pharmaceutical products, readying to compete with companies such as Ranbaxy, Cipla, Sun Pharma and Lupin whose produce they sell.

Remdesivir black-market thrives as Covid cases rise

Remdesivir black-market thrives as Covid cases rise

Rediff.com6 May 2021

Artificial shortages and brazen hawking of the drug on the streets at 15 times the normal price rule the day as the official machinery tries desperately to stamp out the parallel market, reports Sohini Das

India's drug inspectors hard-pressed to scrutinise factories

India's drug inspectors hard-pressed to scrutinise factories

Rediff.com7 Apr 2014

There are just 1,500 drug inspectors responsible for more than 10,000 factories in India

India Inc's Q1 revenue growth to hit a 2-year high

India Inc's Q1 revenue growth to hit a 2-year high

Rediff.com8 Jul 2016

For fast-moving consumer goods, growth is likely to be tepid.

Biological E ties up with US-based Baylor for Covid vaccine

Biological E ties up with US-based Baylor for Covid vaccine

Rediff.com28 Aug 2020

According to BCM, Hyderabad-headquartered BE has licensed the recombinant protein Covid-19 vaccine candidate developed at Baylor.

PM discusses COVID-19, its vaccine with Bill Gates

PM discusses COVID-19, its vaccine with Bill Gates

Rediff.com15 May 2020

During a video conference, Bill and Melinda Gates Foundation co-chair Bill Gates and Prime Minister Modi agreed that given India's willingness and capacity to contribute to global efforts, it was important for New Delhi to be included in the global discussions for coordinating responses to the pandemic.

Exports contract 10.21% in July; trade deficit narrows to $4.83 bn

Exports contract 10.21% in July; trade deficit narrows to $4.83 bn

Rediff.com14 Aug 2020

Sectors with positive growth during the month include rice, iron ore, oil seeds, oil meals, meat, dairy and poultry products, pharmaceuticals, coffee, engineering goods, and plastic.

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Pursuing foreign companies since mid-2020 for possible vaccine imports: Govt

Rediff.com27 May 2021

Facing accusations of delay in placing orders for vaccines, the government on Thursday defended its vaccine procurement policy saying it has been pursuing Pfizer, J&J and Moderna since mid-2020 for the earliest possible imports, and has even waived local trials for well-established foreign vaccine makers.

Can India crack the Russian market?

Can India crack the Russian market?

Rediff.com28 Dec 2014

Trade sanctions on Russia by Europe and the US offer an opportunity for India, but the devaluation of the rouble may play spoilsport

In UNGA address, PM Modi pushes for reforms

In UNGA address, PM Modi pushes for reforms

Rediff.com26 Sep 2020

In his pre-recorded video statement to the landmark General Debate of the 75th session of the United Nations General Assembly, Modi said the stability in the United Nations and empowerment of the world body are essential for the welfare of the world.

Why amendments are necessary for Make in India's success

Why amendments are necessary for Make in India's success

Rediff.com8 Dec 2014

Make in India and Swacch Bharat initiatives are going to have tremendous impact on the Home and Personal Care industry.

New restrictions in Maha from Wednesday. What's allowed and what's not

New restrictions in Maha from Wednesday. What's allowed and what's not

Rediff.com13 Apr 2021

Maharashtra Chief Minister Uddhav Thackeray announced a statewide curfew for 15 days from 8 am on April 14 to contain the rapid spread of the coronavirus in its second wave. With Section 144 being imposed across the state, Thackeray essential services have been exempted from the restrictions. The curfew will be in place till 7 am on May 1.

Must Read: The future of jobs in India

Must Read: The future of jobs in India

Rediff.com26 Dec 2017

'The rule for millennials is: You can have a career for life.' 'You have to constantly adapt to the needs of the industry to stay relevant.' 'The jobs will be the same, but the skill sets required will be different.' 'Technology will dominate the nature of jobs available in the future.'

Student develops device to ensure social distancing

Student develops device to ensure social distancing

Rediff.com25 Mar 2020

The device which can be worn as a pendant comes with a sensor which glows in case someone breaches the user's safe space of one metre and a 'hand wash reminder'.

China offers its COVID vaccine to diplomats, foreign scribes

China offers its COVID vaccine to diplomats, foreign scribes

Rediff.com18 Mar 2021

A notice issued to the foreign journalists on Wednesday said they can get the Inactivated SARS-CoV-2 Vaccine, developed by Sinopharm's China National Biotec Group. Sinopharm's COVID-19 vaccine has been granted conditional market approval by China's National Medical Products Administration.

Oxford jabs effective against severe Covid: US trial

Oxford jabs effective against severe Covid: US trial

Rediff.com22 Mar 2021

The Oxford/AstraZeneca vaccine is also being produced as part of a tie-up by the Serum Institute of India.

Drugmakers draw more FDA scrutiny as US imports rise

Drugmakers draw more FDA scrutiny as US imports rise

Rediff.com13 Sep 2013

And when an inspector asked about the contents of unlabelled vials in the laboratory glassware washing area, a plant worker dumped them down a sink and said the contents could not be determined, according to a July 18 letter from the US Food and Drug Administration to Wockhardt, which makes sterile injectable drugs and various forms of insulin.

Exports growth slides to 4-month low in April; trade gap at 5-month high

Exports growth slides to 4-month low in April; trade gap at 5-month high

Rediff.com15 May 2019

Imports increased by 4.5 per cent, the highest growth in the last six months as crude oil and gold shipments shot up in the month.

India's exports grew 20% in May, but there's a downside

India's exports grew 20% in May, but there's a downside

Rediff.com16 Jun 2018

Despite the 6-month high, trade deficit has widened to a four-month high of $14.62 billion, as imports rose by 14.85 per cent during the month, reports Subhayan Chakraborty.

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Gilead to allow 5 Indian firms to sell hepatitis generics in 90 countries

Rediff.com15 Sep 2014

Among the companies likely to sign deals with Gilead are Cadila, Hetero, Strides Arcolab and Mylan, while Cipla is expected to earn active pharmaceutical ingredient rights.

Germany, France, Italy suspend use of AstraZeneca vaccine

Germany, France, Italy suspend use of AstraZeneca vaccine

Rediff.com15 Mar 2021

The British-Swedish pharmaceutical major and the UK's medicines regulator said that the vaccines produced by Oxford University in collaboration with AstraZeneca to protect against COVID-19 are safe.

7 jobs in DEMAND

7 jobs in DEMAND

Rediff.com27 Jan 2021

There will be a huge market for healthcare professionals, data and security experts and digital marketers, says Navneet Singh, founder, Avsar HR Services.

After ban on drug facilities, US regulator comes calling

After ban on drug facilities, US regulator comes calling

Rediff.com10 Feb 2014

Margaret A Hamburg, the first commissioner of the US Food and Drug Administration (US FDA) to visit India officially, will meet heads of major domestic pharma companies such as Ranbaxy, Wockhardt, Cadila Healthcare and Lupin in New Delhi.

No plans to reduce workforce: Ranbaxy

No plans to reduce workforce: Ranbaxy

Rediff.com2 Oct 2013

The company has been reported to be retrenching staff.

MUST READ: How India, China can work together

MUST READ: How India, China can work together

Rediff.com2 Mar 2019

'As China rises and India grows to reclaim their earlier positions on the world stage as two of the largest economies and most important countries, there will indeed be some contention between these two powers.' 'There will also be plenty of space and room for cooperation amongst the two of us.' 'As our economic size increases to match the fact that we are the two most populous nations on earth, it will be all the more important for us to keep the interests of our peoples as well as those of the rest of the world in mind.' 'We shall have to grow together rather than as separate and disparate entities,' points out Ambassador Gautam Bambawale -- who served as India's ambassador to China -- in the 7th annual lecture of the Indian Association of Foreign Affairs Correspondents on March 1, 2019.

1 in 7 Indian drugs revealed as substandard

1 in 7 Indian drugs revealed as substandard

Rediff.com16 Feb 2016

More lucrative routinely prescribed drugs are at higher risk of failing quality standards

'After Covid, demand will be back with a vengeance'

'After Covid, demand will be back with a vengeance'

Rediff.com11 Dec 2020

'When there is unlocking, there is demand revival.' 'This is going to be the main growth engine in this kind of an economic scenario.'

PM urged to reject US pressure tactics on trade, biz policies

PM urged to reject US pressure tactics on trade, biz policies

Rediff.com28 Mar 2014

The unilateral pressure by US administration on India, at the behest of US Business Associations lobby through US International Trade Commission investigations and request to USTR to enlist India under Priority Foreign Country under Special 301 review, lacks legitimacy under WTO framework, the signatories to the letter said.

Motilal Oswal: 'Demonetisation will hurt growth'

Motilal Oswal: 'Demonetisation will hurt growth'

Rediff.com14 Nov 2016

'India is still a cash economy.' 'For a common household, almost everything from grocery to maid services is paid in cash.' 'The demonetised notes account for 85 per cent of the currency in circulation.' 'Until fresh notes flow back into the economy, day-to-day transactions ordinarily done in cash will be impacted.'

If there is one Modi idea I can get behind, it is Swachh Bharat

If there is one Modi idea I can get behind, it is Swachh Bharat

Rediff.com14 Jul 2018

'As an idea, cleaning up India is a good one,' says Mitali Saran.

The A to Z of 2020

The A to Z of 2020

Rediff.com31 Dec 2020

We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.